Sources | Names Used |
---|---|
CCLE, FIMM | Irinotecan |
gCSI | irinotecan |
GRAY | CPT-11 |
PharmacoGx | Irinotecan |
Database | Identifier |
---|---|
Smiles: | CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7 |
Inchikey: | UWKQSNNFCGGAFS-XIFFEERXSA-N |
Pubchem: | 60838 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ORC1 | CCLE | pan-cancer | AAC | 0.32 | 2e-08 |
mRNA | CNTRL | CCLE | pan-cancer | AAC | 0.32 | 2e-05 |
mRNA | HNRNPC | CCLE | pan-cancer | AAC | 0.32 | 7e-09 |
mRNA | TMPO | CCLE | pan-cancer | AAC | 0.32 | 1e-08 |
mRNA | FBXO5 | CCLE | pan-cancer | AAC | 0.32 | 2e-08 |
mRNA | DAZAP1 | CCLE | pan-cancer | AAC | 0.31 | 3e-07 |
mRNA | CRLF3 | CCLE | pan-cancer | AAC | 0.31 | 2e-07 |
mRNA | DAZAP1 | gCSI | pan-cancer | AAC | 0.31 | 6e-08 |
mRNA | PLEK | gCSI | pan-cancer | AAC | 0.3 | 7e-05 |
mRNA | ATG4C | gCSI | pan-cancer | AAC | 0.3 | 1e-07 |